Al Aqar Healthcare Stock Current Valuation
| 5116 Stock | 1.37 0.02 1.44% |
Valuation analysis of Al Aqar Healthcare helps investors to measure Al Aqar's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Al Aqar's price fluctuation is moderately volatile at this time. Calculation of the real value of Al Aqar Healthcare is based on 3 months time horizon. Increasing Al Aqar's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 5116 stock is determined by what a typical buyer is willing to pay for full or partial control of Al Aqar Healthcare. Since Al Aqar is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 5116 Stock. However, Al Aqar's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.37 | Real 1.35 | Hype 1.37 | Naive 1.37 |
The intrinsic value of Al Aqar's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Al Aqar's stock price.
Estimating the potential upside or downside of Al Aqar Healthcare helps investors to forecast how 5116 stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Al Aqar more accurately as focusing exclusively on Al Aqar's fundamentals will not take into account other important factors: Al Aqar Healthcare Company Current Valuation Analysis
Al Aqar's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Al Aqar Current Valuation | 1.52 B |
Most of Al Aqar's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Al Aqar Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Al Aqar Healthcare has a Current Valuation of 1.52 B. This is 90.01% lower than that of the Real Estate sector and significantly higher than that of the Residential & Commercial REITs industry. The current valuation for all Malaysia stocks is 90.89% higher than that of the company.
5116 Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Al Aqar's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Al Aqar could also be used in its relative valuation, which is a method of valuing Al Aqar by comparing valuation metrics of similar companies.Al Aqar is currently under evaluation in current valuation category among its peers.
5116 Fundamentals
| Return On Equity | 7.98 | |||
| Current Valuation | 1.52 B | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 8.38 X | |||
| Revenue | 114.07 M | |||
| EBITDA | 99.22 M | |||
| Net Income | 72.78 M | |||
| Total Debt | 683.88 M | |||
| Cash Flow From Operations | 88.58 M | |||
| Market Capitalization | 897.9 M | |||
| Total Asset | 1.66 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 1.66 B | |||
| Last Dividend Paid | 0.077 |
About Al Aqar Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Al Aqar Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Al Aqar using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Al Aqar Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 5116 Stock
Al Aqar financial ratios help investors to determine whether 5116 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 5116 with respect to the benefits of owning Al Aqar security.